LeMaitre Vascular (LMAT)

Nasdaq Health Care Health Care Equipment S&P SmallCap 600

$80.89

-2.60 (-3.11%)

Close of Nov 06, 2026 · end-of-day data

Source: LeMaitre Vascular's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 06, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$89.15M	$100.87M	$105.57M	$117.23M	$129.37M	$154.42M	$161.65M	$193.48M	$219.86M	$249.60M
Cost of revenue	$26.21M	$30.17M	$31.63M	$37.38M	$44.75M	$53.04M	$56.76M	$66.44M	$68.96M	$71.06M
Gross profit	$62.94M	$70.70M	$73.94M	$79.85M	$84.62M	$101.38M	$104.90M	$127.05M	$150.90M	$178.54M
Research & development	$6.14M	$6.64M	$8.20M	$9.28M	$10.10M	$11.80M	$13.29M	$16.97M	$15.65M	$14.14M
Operating income	$16.34M	$21.10M	$28.21M	$21.18M	$28.79M	$36.42M	$26.83M	$36.71M	$52.26M	$67.91M
Interest expense	$14.00K	$21.00K	$2.00K	$0	$1.31M	$2.22M	$0	$0	$205.00K	$5.18M
Pre-tax income	$16.24M	$21.11M	$28.44M	$21.68M	$27.36M	$34.29M	$27.49M	$39.48M	$56.88M	$75.18M
Income tax	$5.65M	$3.93M	$5.50M	$3.75M	$6.14M	$7.38M	$6.85M	$9.37M	$12.84M	$17.45M
Net income	$10.59M	$17.18M	$22.94M	$17.93M	$21.22M	$26.91M	$20.64M	$30.11M	$44.04M	$57.73M
EBITDA	$19.93M	$25.16M	$32.53M	$26.60M	$37.18M	$47.49M	$36.26M	$46.23M	$61.86M	$78.33M
EPS (basic)	$0.57	$0.91	$1.18	$0.91	$1.05	$1.27	$0.94	$1.36	$1.96	$2.55
EPS (diluted)	$0.55	$0.86	$1.13	$0.88	$1.04	$1.25	$0.93	$1.34	$1.93	$2.52
Diluted shares	19.24M	20.03M	20.24M	20.33M	20.48M	21.48M	22.17M	22.42M	22.78M	22.93M
Gross margin	70.6%	70.1%	70.0%	68.1%	65.4%	65.7%	64.9%	65.7%	68.6%	71.5%
Operating margin	18.3%	20.9%	26.7%	18.1%	22.3%	23.6%	16.6%	19.0%	23.8%	27.2%
Net margin	11.9%	17.0%	21.7%	15.3%	16.4%	17.4%	12.8%	15.6%	20.0%	23.1%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$24.29M	$19.10M	$26.32M	$11.79M	$26.76M	$13.86M	$19.13M	$24.27M	$25.61M	$28.24M
Short-term investments	—	—	—	—	$214.00K	$56.10M	$63.56M	$80.81M	$274.11M	$330.88M
Receivables	$13.19M	$15.00M	$15.72M	$16.57M	$19.55M	$19.63M	$22.04M	$25.06M	$30.06M	$33.61M
Inventory	$19.58M	—	—	—	—	—	—	—	—	—
Total current assets	$59.03M	$80.31M	$94.02M	$92.09M	$94.26M	$139.88M	$161.73M	$194.60M	$402.19M	$468.23M
Goodwill	$23.43M	$23.84M	$29.87M	$39.95M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M
Total assets	$101.92M	$126.32M	$153.09M	$188.34M	$252.81M	$292.80M	$310.48M	$346.78M	$551.82M	$615.69M
Total current liabilities	$10.48M	$13.19M	$19.76M	$20.85M	$25.14M	$21.81M	$25.33M	$29.88M	$30.61M	$36.32M
Total liabilities	$14.42M	$16.55M	$22.85M	$40.20M	$80.24M	$38.65M	$42.27M	$48.88M	$214.53M	$222.17M
Shareholders' equity	$87.50M	$109.77M	$130.24M	$148.14M	$172.57M	$254.15M	$268.20M	$297.90M	$337.29M	$393.52M

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$16.90M	$22.87M	$19.51M	$14.18M	$34.80M	$35.10M	$25.38M	$36.75M	$44.12M	$81.25M
Capital expenditures	$2.84M	$6.42M	$3.05M	$3.76M	$2.98M	$4.88M	$3.23M	$7.26M	$6.96M	$6.78M
Free cash flow	$14.05M	$16.45M	$16.45M	$10.42M	$31.82M	$30.22M	$22.15M	$29.49M	$37.16M	$74.47M
Investing cash flow	-$17.21M	-$28.96M	-$7.05M	-$24.10M	-$52.89M	-$61.08M	-$10.37M	-$24.71M	-$200.12M	-$64.94M
Financing cash flow	-$2.58M	$80.00K	-$4.42M	-$4.62M	$32.16M	$13.70M	-$9.23M	-$7.13M	$158.10M	-$14.54M
Dividends paid	$3.32M	$4.18M	$5.45M	$6.74M	$7.70M	$9.34M	$10.99M	$12.45M	$14.38M	$18.11M
Share buybacks	$311.00K	$778.00K	$741.00K	$683.00K	$570.00K	$802.00K	$642.00K	$853.00K	$1.72M	$1.82M
Stock-based compensation	$1.68M	$2.26M	$2.35M	$2.64M	$3.02M	$3.48M	$4.17M	$5.32M	$6.57M	$7.83M
Depreciation & amortization	$3.59M	$4.05M	$4.32M	$5.42M	$8.39M	$11.07M	$9.43M	$9.52M	$9.61M	$10.42M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$48.88M	$53.48M	$55.85M	$54.82M	$55.72M	$59.87M	$64.23M	$61.05M	$64.45M	$66.55M	$70.38M	$67.97M
Cost of revenue	$15.62M	$16.81M	$17.38M	$17.64M	$17.13M	$18.45M	$19.26M	$15.09M	$18.26M	$18.16M	$19.62M	$19.27M
Gross profit	$33.27M	$36.66M	$38.47M	$37.18M	$38.59M	$41.42M	$44.97M	$45.95M	$46.19M	$48.40M	$50.76M	$48.70M
Research & development	$4.35M	$4.09M	$4.28M	$3.66M	$3.62M	$4.09M	$3.54M	$2.97M	$3.53M	$4.06M	$4.85M	$4.42M
Operating income	$10.21M	$11.87M	$14.38M	$13.15M	$12.85M	$12.63M	$16.14M	$20.31M	$18.83M	$17.77M	$20.40M	$17.70M
Interest expense	—	$0	$0	$0	$205.00K	$1.29M	$1.30M	$1.30M	$1.30M	$1.30M	$1.30M	$1.30M
Pre-tax income	$11.31M	$12.80M	$15.51M	$14.55M	$14.02M	$14.24M	$18.07M	$22.57M	$20.30M	$19.67M	$22.19M	$19.67M
Income tax	$2.85M	$2.91M	$3.68M	$3.41M	$2.84M	$3.23M	$4.29M	$5.21M	$4.72M	$3.99M	$5.14M	$4.65M
Net income	$8.46M	$9.89M	$11.83M	$11.14M	$11.18M	$11.01M	$13.78M	$17.36M	$15.58M	$15.68M	$17.05M	$15.02M
EBITDA	$12.65M	$14.26M	$16.76M	$15.57M	$15.27M	$15.18M	$18.79M	$22.93M	$21.44M	$20.40M	$23.06M	$20.58M
EPS (basic)	$0.38	$0.44	$0.53	$0.50	$0.50	$0.49	$0.61	$0.77	$0.69	$0.69	$0.75	$0.66
EPS (diluted)	$0.38	$0.44	$0.52	$0.49	$0.48	$0.48	$0.60	$0.75	$0.68	$0.68	$0.74	$0.65
Diluted shares	12.00K	22.57M	22.73M	22.84M	56.00K	22.90M	22.89M	24.39M	14.00K	23.03M	24.53M	23.07M
Gross margin	68.1%	68.6%	68.9%	67.8%	69.3%	69.2%	70.0%	75.3%	71.7%	72.7%	72.1%	71.7%
Operating margin	20.9%	22.2%	25.7%	24.0%	23.1%	21.1%	25.1%	33.3%	29.2%	26.7%	29.0%	26.0%
Net margin	17.3%	18.5%	21.2%	20.3%	20.1%	18.4%	21.5%	28.4%	24.2%	23.6%	24.2%	22.1%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$24.27M	$26.59M	$22.27M	$21.00M	$25.61M	$25.34M	$27.18M	$25.49M	$28.24M	$26.85M	$26.62M	$27.49M
Short-term investments	$80.81M	$81.69M	$90.83M	$102.89M	$274.11M	$277.21M	$292.31M	$317.56M	$330.88M	$340.38M	$349.62M	$362.23M
Receivables	$25.06M	$30.24M	$30.82M	$32.27M	$30.06M	$35.11M	$36.54M	$32.42M	$33.61M	$35.77M	$35.68M	$35.88M
Total current assets	$194.60M	$202.96M	$212.81M	$227.12M	$402.19M	$408.11M	$430.13M	$452.02M	$468.23M	$477.82M	$488.30M	$505.51M
Goodwill	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M	$65.94M
Total assets	$346.78M	$353.96M	$363.08M	$377.02M	$551.82M	$556.01M	$577.59M	$598.07M	$615.69M	$629.53M	$640.55M	$656.03M
Total current liabilities	$29.88M	$26.81M	$25.45M	$29.34M	$30.61M	$24.75M	$30.82M	$33.29M	$36.32M	$33.37M	$29.93M	$34.62M
Total liabilities	$48.88M	$45.45M	$43.55M	$45.95M	$214.53M	$208.43M	$214.91M	$219.15M	$222.17M	$222.90M	$220.21M	$223.90M
Shareholders' equity	$297.90M	$308.50M	$319.53M	$331.07M	$337.29M	$347.57M	$362.69M	$378.92M	$393.52M	$406.62M	$420.34M	$432.13M

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$10.75M	$5.07M	$9.62M	$14.25M	$15.18M	$9.04M	$20.29M	$28.76M	$23.16M	$15.09M	$15.96M	$21.99M
Capital expenditures	$1.28M	$1.37M	$1.88M	$1.67M	$2.04M	$1.38M	$1.34M	$2.28M	$1.78M	$2.78M	$2.31M	$2.33M
Free cash flow	$9.47M	$3.70M	$7.75M	$12.58M	$13.14M	$7.66M	$18.95M	$26.48M	$21.38M	$12.31M	$13.65M	$19.66M
Investing cash flow	-$2.26M	-$2.36M	-$11.00M	-$12.86M	-$173.89M	-$4.32M	-$16.35M	-$27.45M	-$16.82M	-$13.12M	-$11.08M	-$16.21M
Financing cash flow	-$2.69M	$39.00K	-$2.87M	-$3.15M	$164.08M	-$5.24M	-$2.76M	-$2.95M	-$3.59M	-$3.22M	-$5.05M	-$4.97M
Dividends paid	$3.12M	$3.59M	$3.59M	$3.60M	$3.60M	$4.52M	$4.52M	$4.54M	$4.54M	$5.71M	$5.72M	$5.72M
Share buybacks	$667.00K	$358.00K	$7.00K	$1.00K	$1.35M	$601.00K	$4.00K	$0	$1.22M	$460.00K	$17.00K	$0
Stock-based compensation	$1.40M	$1.61M	$1.61M	$1.61M	$1.74M	$2.05M	$1.94M	$1.74M	$2.10M	$2.09M	$1.94M	$2.03M
Depreciation & amortization	$2.44M	$2.38M	$2.38M	$2.43M	$2.42M	$2.55M	$2.65M	$2.61M	$2.60M	$2.62M	$2.66M	$2.88M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.